1. Moscone West 2005

It is critical to come to ground truth when high consequence vulnerabilities are discovered in medical devices. The FDA is exploring the development and viability of a Cyber Med Safety Analysis Board to integrate critical patient safety and clinical environment dimensions into the assessment and validation of high-risk/high-impact device vulnerabilities and incidents.

Pre-Requisites: Familiarity with medical devices and their use within the clinical environment; familiarity with the medical device regulatory environment.

Participants: